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Aims It is uncertain if the higher blood pressure (BP) observed in the offspring of hypertensive pregnancies is an isolated
abnormality or one that is accompanied by impaired vascular function and alterations in lipid and inﬂammation
markers that would be indicative of a more general cardiometabolic disturbance of the type observed in the
mother during pre-eclampsia.
Methods and
results
In a large UK cohort of maternal-offspring pairs (n ¼ 3537–4654), assessed at age 9–12 years, we examined the
associations of maternal gestational hypertension and pre-eclampsia with offspring BP, endothelial function assessed
by brachial artery ﬂow-mediated dilatation; arterial stiffness assessed by carotid to radial pulse wave velocity; brachial
artery distensibility and BP (vascular outcomes); as well as markers of inﬂammation, lipids and apolipoproteins A1 and
B. Offspring of women with pre-eclampsia or gestational hypertension had higher systolic blood pressure by
2.04 mmHg (95% CI: 1.33, 2.76) and 1.82 mmHg (95% CI: 0.03, 3.62), respectively, and higher diastolic blood
pressure by 1.10 mmHg (95% CI: 0.47, 1.73) and 1.26 mmHg (95% CI: 20.32, 2.85), respectively, in analyses adjusted
for maternal and offspring body mass index (BMI), offspring dietary sodium intake and other potential confounders.
However, we found no associations of either hypertensive disorder of pregnancy with the other vascular outcomes
or with inﬂammatory markers, lipids, and apolipoproteins.
Conclusion Pre-eclampsia and gestational hypertension are associated with higher offspring BP in childhood in the absence of
other vascular alterations or metabolic derangements. The ﬁndings support the existence of shared mother-offspring
risk factors that are speciﬁc for higher BP, rather than the additional cardiometabolic abnormalities of hypertensive
disorder of pregnancy having long-term consequences for offspring.
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Pre-eclampsia or gestational hypertension (hypertensive disorders
of pregnancy; HDP) is associated with adverse perinatal outcomes
for the mother and neonate, and also with higher maternal and off-
spring blood pressure in later life,
1–7 though the mechanisms
underlying the association with later offspring blood pressure
remain unclear.
8
Pre-eclampsia is a disease characterized by systemic inﬂam-
mation, endothelial dysfunction, and insulin resistance in the preg-
nant mother.
9–12 It has been suggested that these systemic
inﬂuences result in as yet undetermined vasculotoxic factors
being released into the maternal circulation that have adverse inﬂu-
ences on foetal development. This, it has been suggested, results in
increased risk of vascular dysfunction and chronic inﬂammation in
later life of the offspring.
13 If this hypothesis were true one would
anticipate associations of pre-eclampsia with offspring endothelial
dysfunction, other markers of vascular dysfunction and markers
of chronic inﬂammation in later life, but few studies have examined
these associations. In contrast if associations of both pre-eclampsia
and gestational hypertension with offspring outcomes are speciﬁc
to blood pressure, this would suggest that the underlying mechan-
ism is more likely to be due to inherited genetic variants that are
related to higher blood pressure or shared familial environmental
factors that are speciﬁcally (or much more strongly) related to
blood pressure, rather than intrauterine mechanisms. Dietary
sodium intake is a speciﬁc risk factor for higher blood pressure
and, thus, it may underlie associations between higher maternal
blood pressure in pregnancy and higher offspring blood pressure.
In one small study, preterm infants born of mothers with HDP
(either pre-eclampsia or gestational hypertension; n ¼ 19) had
lower ﬂow-mediated dilatation (FMD), a marker of endothelial dys-
function, as well as higher blood pressure and thicker carotid
intima in their mid-20s, than a group who had been born
preterm but whose mothers were normotensive throughout preg-
nancy (n ¼ 52).
14 The authors of that study interpreted their ﬁnd-
ings as indicating that either genetic predisposition to endothelial
dysfunction or the exposure in utero to inﬂammatory markers
were important in explaining the link between HDP and future off-
spring risk of an unhealthy vascular phenotype. In a more recent
study of term infants, those whose mothers had pre-eclampsia
during pregnancy (n ¼ 24) had lower FMD and higher pulmonary
arterial pressure in their teens, but similar blood pressure and bra-
chial arterial diameter to age-matched controls (n ¼ 27).
13 The
authors suggested that their results supported an intrauterine
mechanism driven by the release of vascular toxins (including
inﬂammatory markers) into the maternal and developing foetal cir-
culation. They further explored this in a within sibling study and
found that among 10 sibling pairs FMD was lower and pulmonary
arterial pressure higher in the sibling exposed to maternal
pre-eclampsia compared with the one born later during a
normal pregnancy, suggesting that the mechanism was at least in
part via intrauterine mechanisms rather than fully explained by
shared familial lifestyles or genetic factors related to vascular
dysfunction.
13
The aim of this study was to examine the association of HDP
with offspring vascular outcomes [endothelial function assessed
by brachial artery FMD, arterial stiffness assessed by carotid to
radial pulse wave velocity (PWV), brachial distensibility coefﬁcient
(DC), brachial artery diameter, and systolic blood pressure (SBP)
and diastolic blood pressure (DBP)]; markers of inﬂammation
[C-reactive protein and Interluekin-6 (IL-6)]; lipids [triglyceride
levels, high density lipoprotein cholesterol (HDLc), non-HDLc];
and apolipoproteins A1 and B, assessed in offspring at age 9–12
years in a large UK cohort of children who have been followed
since their mother’s pregnancy. This builds on an earlier publi-
cation in which associations with blood pressure only were
examined.
1
Methods
Study population
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a
prospective population-based birth cohort study that recruited
14 541 pregnant women resident in Avon, UK with expected dates
of delivery 1 April 1991 to 31 December 1992 (http://www.alspac.
bris.ac.uk).
15 Figure 1 shows the ﬂow of participants through the
study. In this study, we only included mother-offspring pairs where
there was a singleton pregnancy resulting in a live birth with the
child surviving to at least 1 year of age. The eligible cohort for the
current analyses was the 4675 mother-offspring pairs who had com-
plete data on maternal HDP and offspring blood assays of inﬂamma-
tory markers, lipids, and apolipoproteins (obtained at the 9–10-year
follow-up clinic) and the 6550 pairs who had complete data on HDP
and had vascular outcome data (obtained at the 10–11-year follow-up
clinic).
Maternal pregnancy data
Six trained research midwives abstracted data from obstetric medical
records. There were no between-midwife variation in mean values
of abstracted data and repeated data entry checks demonstrated
error rates consistently ,1%. Obstetric data abstractions included
every measurement of SBP, DBP, and proteinuria entered into the
medical records and the corresponding gestational age and date at
the time of these measurements. These measurements were obtained
in routine clinical practice by trained midwives and obstetricians. The
median number (inter-quartile range) of BP measurements in preg-
nancy was 14 (11, 16) and that of urine measurements was 11
(10, 14). We applied the International Society for the Study of Hyper-
tension in Pregnancy
16 criteria to all of the clinic data in order to deter-
mine women with pre-eclampsia and those with gestational
hypertension. Using these criteria pre-eclampsia was deﬁned as a
SBP .139 mmHg or a DBP .89 mmHg, measured on at least two
occasions after 20 weeks of gestation, with proteinuria, diagnosed if
the protein reading on dipstick testing (Albustix; Ames Company,
Elkhart, IN, USA) was at least 1+ (30 mg/dL), occurring at the same
time as the elevated BP.
16 Gestational hypertension was deﬁned as
the same pattern of elevated blood pressure but without proteinuria.
16
Thus, all women were categorized into one of three mutually exclusive
categories of no HDP, gestational hypertension, or pre-eclampsia.
A total of 12 women with either pre-eclampsia or gestational hyper-
tension and 9 with no evidence of HDP, reported a previous diagnosis
of hypertension unrelated to pregnancy; none of these women were
on antihypertensive treatment. A further 13 women had blood
pressure ≥139/89 on at least two occasions prior to 20 weeks ges-
tation (again none was on antihypertensive medication). When these
D.A. Lawlor et al. 33625 women were excluded from the analyses the results were
unchanged from those presented here that include them.
Offspring outcome measurements
Current age of the child was recorded in months as they arrived at the
assessment clinics. Inﬂammatory markers, lipids, and apolipoproteins
were assessed at the 9–10-year assessment. Non-fasting blood
samples were taken using standard procedures, with samples immedi-
ately spun and frozen at 2808C. The measurements were assayed
after a median of 7.5 years in storage with no previous freeze–thaw
cycles during this period. Plasma lipids (total cholesterol, triglycerides,
and HDLc) were assayed by modiﬁcation of the standard Lipid
Research Clinics Protocol using enzymatic reagents for lipid determi-
nation. Apolipoprotein A1 and B were measured by immunoturbidi-
metric assays (Hitachi/Roche). Interluekin-6 was measured by ELISA
(R&D systems, Abingdon, UK) and C-reactive protein was measured
by automated particle-enhanced immunoturbidimetric assay (Roche
UK, Welwyn Garden City, UK). Non-HDLc was calculated as total
cholesterol minus HDLc.
Vascular phenotypes were assessed at the 10–11-year follow-up
assessment and detailed descriptions of the measurements have
been previously reported.
17 For PWV, pressure pulse waveforms
were recorded transcutaneously using a high-ﬁdelity micromanometer
(SPC-301, Millar Instruments, Houston, TX, USA) from the radial and
carotid pulse, synchronous with the ECG signal. Integral software pro-
cessed the data to calculate the mean time difference between R-wave
and pressure wave on a beat-to-beat basis over 10 s, and the PWV was
then calculated using the mean time difference and arterial path length
between the two recording points (SphygmoCorversion 7.1, Scanmed,
UK). Ultrasound images of the right brachial artery were used to
measure FMD and DC. Images were recorded onto SVHS video
using an ALOKA 5500 high-resolution ultrasound system with a
5–10 MHz linear array probe (Keymed, UK) and the measurements
were undertaken later from the videos at the Vascular Physiology
Unit, Institute of Child Health, London. The right brachial artery was
imaged 5–10 cm above the antecubital fossa. Flow-mediated dilatation
was induced by a 5-min inﬂation of a pneumatic cuff, placed around the
forearm immediately below the medial epicondyle, to 200 mmHg fol-
lowed by rapid deﬂation using an automatic air regulator. The diameter
of the brachial artery was measured using edge detection software
(Brachial Tools, MIA, IA, USA) from ECG-triggered ultrasound
images captured at 3 s intervals throughout the 11-min recording pro-
tocol. Flow-mediated dilatation was expressed as an absolute value in
our analyses. Flow-mediated dilatation expressed as the maximum per-
centage change in vessel diameter from baseline correlated very highly
with this absolute value (Pearson’s correlation coefﬁcient ¼ 0.95) and
ﬁndings were essentially the same if % change was used rather than the
absolute value. The distension of the artery was determined by
measuring the luminal diameter excursion from diastole to systole.
Distensibility coefﬁcient was calculated from the distension and the
pulse pressure and was expressed as mean per cent change in cross-
sectional area per unit change in blood pressure.
Other characteristics
Maternal age, parity, mode of delivery (caesarean section/vaginal deliv-
ery), gestational age at delivery, and the child’s sex and birthweight
were obtained from the obstetric records. At the time of recruitment,
mothers were asked to report their pre-pregnancy weight and height,
which were used to calculate maternal pre-pregnancy body mass index
(BMI). Maternal self-report of pre-pregnancy weight and her measured
weight at the ﬁrst antenatal clinic were highly correlated (Pearson’s
correlation coefﬁcient ¼ 0.95; P , 0.0001). Based on questionnaire
Figure 1 Participant ﬂow
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children to family social class groups [classes I (professional/manage-
rial) to V (unskilled manual workers), using the 1991 British Ofﬁce
of Population and Census Statistics (OPCS) classiﬁcation]. Mothers
were repeatedly asked about their smoking throughout pregnancy
and these data were used to generate a categorical variable: never
smoked; smoked before pregnancy or in the ﬁrst trimester and then
stopped; smoked throughout pregnancy.
At both clinic assessments, the child’s age in months was recorded
and their weight and height were measured in light clothing and
without shoes. Weight was measured to the nearest 0.1 kg using
Tanita scales. Height was measured to the nearest 0.1 cm using a Har-
penden stadiometer. Waist circumference was measured to the
nearest 1 mm at the mid-point between the lower ribs and the
pelvic bone with a ﬂexible tape. Dual energy X-ray absorptiometry
(DXA) scans were used to measure total fat mass.
At the same time as the vascular measurements (mean age: 10.7),
offspring diet was assessed using three 1-day unweighed dietary
diaries in which children and carers recorded everything the child
ate and drank in household measures for 2 weekdays and 1
weekend day. Data from these diaries were used to determine off-
spring dietary sodium (salt) intake. Completed diaries were brought
to the clinic and nutrition ﬁeldworkers checked through the diaries
to increase completeness and remove uncertainties. Diet diaries
were transformed into food codes with associated weights in
grams for each item of food and drink recorded, by the same ﬁeld-
worker using the Diet in, Diet out (DIDO) programme.
18 Food
codes and nutrient content, including sodium content, were
derived from McCance and Widdowsons food tables and
supplements.
18
Statistical analysis
Triglyceride, C-reactive protein, IL-6 levels, DXA-determined fat mass,
and DC were positively skewed and were natural log transformed to
produce approximately normal distributions and normal residuals in
the regression models. In the descriptive analyses, for these variables,
geometric means are presented. In the regression analyses, associ-
ations of HDP with outcomes that were log transformed are presented
as ratios of geometric means. Pearson’s correlation coefﬁcients were
used to explore associations between all outcomes using the 3062 par-
ticipants with complete data on both sets of outcomes (Figure 1).
To obtain reliable 95% conﬁdence intervals in the context of mul-
tiple comparisons, we used a non-parametric bootstrap procedure in
conjunction with OLS multivariable linear regression, based on
10 000 replications. Beta estimates and standard errors were calcu-
lated from the mean and standard deviation of the bootstrap distri-
bution, respectively. The bootstrap means and standard errors,
compared with a z-distribution, were used to calculate the 95% per-
centile conﬁdence intervals. Multivariable linear regression was used
to examine the associations of pre-eclampsia vs. no HDP and gesta-
tional hypertension vs. no HDP with each outcome. In the basic
model, we adjusted only for the child’s gender and age at the time
of outcome measurement. We then adjusted for maternal character-
istics that could confound the association (model 2)—maternal age,
parity, pre-pregnancy BMI, smoking during pregnancy, and education,
head of household social class. In model 3, we adjusted for offspring
adiposity (BMI in the main analyses, but showing that substituting
BMI for either fat mass or waist circumference, did not result in differ-
ent effects to adjusting only for BMI). While offspring BMI occurs after
the exposure, we consider it part of a confounding pathway via its
relationship to maternal BMI.
1 For vascular outcomes only, we then
adjusted for offspring dietary sodium intake (model 4). As with
offspring BMI, while this was measured after the exposure of HDP,
we considered it to be potentially part of a confounding pathway
reﬂecting familial dietary sodium intake, high levels of which in the
mothers could result in increased risk of HDP and increased likelihood
of their offspring having a high intake, which would result in higher off-
spring blood pressure. In the ﬁnal model (model 4 for blood-based
outcomes and 5 for vascular outcomes) we adjusted for possible
mediation by markers of intrauterine mechanisms (gestational age,
mode of delivery and birthweight). Lastly, as blood pressure is associ-
ated with most of the other vascular and biomarker outcomes that we
have examined here, if we found any associations of HDP with other
vascular outcomes these may be generated entirely or in part by the
association of HDP with offspring blood pressure. We examined this
by adjusting for SBP or DBP (ﬁrst entering SBP and then removing it
and entering DBP) in any regression models where an association
was found between HDP and one of the other outcomes.
Because a previous study had suggested that HDP was associated
with offspring endothelial dysfunction only in offspring who were
born preterm,
14 we examined whether there was any evidence
that associations differed between those born preterm (gestational
age ,37 complete weeks) and those born term (≥37 complete
weeks gestation). A likelihood ratio test was used to examine the
interaction between preterm/term and HDP in their associations
with outcomes.
Dealing with missing data
There were small amounts of missing data on some covariables
included in the multivariable models (Figure 1). Of the 4088 partici-
pants who attended the 9–10-year follow-up clinic and provided a
blood sample, 3537 (86%) had complete data on all outcomes,
exposure, and covariables included in any model. Of the 6550 partici-
pants who attended the 10–11-year follow-up clinic and completed
the vascular assessment, 4654 (71%) had complete data on all out-
comes, exposure, and covariables included in any model. We under-
took sensitivity analyses aimed at exploring whether missing data
might have biased our results. In two of these, we only imputed
missing covariable data and so conducted analyses on the 4088
mother-offspring pairs who had complete data on HDP and blood-
based assays for the analyses with these outcomes and on the 6550
pairs with complete data on HDP and vascular outcomes for these
outcomes. In a further two, we extended the imputation data sets
by imputing up to the 6664 mother-offspring pairs where the offspring
had attended the 9–10-year clinic (irrespective of whether they gave a
blood sample) and the 6919 pairs who attended the 10–11 clinic (irre-
spective of whether the undertook any of the vascular outcome
measurements). Finally, we imputed up to 8665 mother-offspring
pairs where the offspring had attended either of the 9–10- or 10–
11-year clinic. In all of these analyses, we used multivariable multiple
imputation in Stata as described by Royston.
19 We carried out 20
cycles of regression switching and generated 20 imputation data sets.
The multiple multivariate imputation approach creates a number of
copies of the data (in this case, we generated 20 copies) in which
missing values are imputed by chained equations.
19 The main analysis
results are obtained by averaging across the results from each of
these 20 data sets using Rubin’s rules which ensure that the standard
errors for any regression coefﬁcients take account of uncertainty in the
imputations as well as uncertainty in the estimation.
19 The results from
these sensitivity analyses did not differ substantively from the results
presented here based only on those with complete data (main analysis
cohorts in Figure 1); these results are available from the authors on
request.
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Among the 13 459 eligible women with complete obstetric data
(Figure 1), 11 043 (82%) had no HDP, 2097 (16%) had gestational
hypertension, and 319 (2%) had pre-eclampsia. Proportions were
similar in the 6550 who attended the vascular clinic [5368 (82%)
no HDP; 1039 (16%) with gestational hypertension; 143 (2%)
with pre-eclampsia] and the 4088 who had blood assay results
[3327 (81%) no HDP; 689 (17%) with gestational hypertension;
88 (2%) with pre-eclampsia]; they were also similar in the groups
with complete data on all covariables (see Tables 2 and 3 for
numbers in each category). Table 1 shows the correlations
between all outcomes in the 3062 participants with data from
both the 9.9-year clinic at which blood-based assays were obtained
and the 10.7-year clinic at which vascular measurements were
obtained, as well as data on HDP and all covariables. Even
where statistically signiﬁcant at conventional 5% levels, the majority
of correlations were weak. Expected strong positive correlations
were observed between HDLc and Apolipoprotein A1,
non-HDLc and Apolipoprotein B, and C-reactive protein and
IL-6 and strong inverse correlations between HDLc and
triglycerides.
Table 2 shows the distributions of potential confounding and
mediating characteristics, as well as outcomes by whether the
mother had no HDP, gestational hypertension, or pre-eclampsia.
Women with either gestational hypertension or pre-eclampsia
compared with those without HDP had higher pre-pregnancy
BMI, were more likely to be in their ﬁrst pregnancy, less likely to
smoke and more likely to have a caesarean section; their offspring
were more likely to be male, had earlier gestational age, lower
birthweight and had greater mean BMI, waist circumference and
fat mass at mean age 9.9 years. Other potential covariables did
not vary by HDP category. With respect to outcomes, both off-
spring SBP and DBP assessed at mean age 10.7 years were
greater in those whose mothers had experienced either gestational
hypertension or pre-eclampsia (consistent with our previous paper
where these were measured at age 9.9 years
1). Mean brachial
diameter was slightly higher in offspring of mothers who had pre-
viously experienced gestational hypertension, but slightly lower in
those who had previously experienced pre-eclampsia. None of the
distributions of the other vascular phenotypes, lipids, apolipopro-
teins, or inﬂammatory markers differed by HDP status in these
unadjusted analyses.
Table 3 shows the multivariable associations of HDP with lipids,
apolipoproteins, and inﬂammatory markers, assessed at mean age
9.9 years, in the 3537 participants with complete data exposure,
blood-based outcomes and any covariables included in any
model. With the exception of inﬂammatory markers, there were
no associations of HDP with any of the blood-based outcomes
in any models. Both C-reactive protein and IL-6 were elevated in
offspring whose mothers had experienced either gestational
hypertension or pre-eclampsia in the ﬁrst model adjusting only
for the offspring sex and age at outcome assessment, but following
adjustment for maternal confounding factors (model 2) these
associations attenuated to the null and remained null in the
mediator adjusted models (models 3 and 4).
Of the 3537 participants included in multivariable analyses of
associations with blood-based outcomes, 169 (5%) were born
preterm. Associations in this subgroup born preterm were the
same as those in offspring born at term, with point estimates all
being very similar in the two groups and the P-values for inter-
action all being .0.3.
Table 4 shows the multivariable associations of HDP with vascu-
lar outcomes assessed at mean age 10.7 in the 4654 participants
with complete data exposures, vascular outcomes, and on all cov-
ariables included in any models. Consistent with our previous pub-
lication with blood pressure measured at age 9.9 years, offspring of
mothers who had experienced either gestational hypertension or
pre-eclampsia had higher mean SBP and DBP in the ﬁrst model.
There was some attenuation with adjustment for maternal con-
founders, largely due to adjustment for maternal BMI and some
further attenuation with adjustment for offspring BMI (model 1).
However, positive associations remained even with these adjust-
ments. After adjustment for confounders, including maternal and
offspring BMI, the positive associations were stronger for SBP
( 2 mmHg greater in offspring whose mothers had either gesta-
tional hypertension or pre-eclampsia) than DBP ( 1 mmHg
greater for each exposure). The associations were similar for
gestational hypertension as they were for pre-eclampsia, though
for the association of pre-eclampsia with DBP the conﬁdence
intervals were wide and included the null value. Adjustment for
dietary sodium intake resulted in some attenuation of the associ-
ation of pre-eclampsia with SBP and DBP, though positive associ-
ations remained, but did not alter associations of gestational
hypertension with these outcomes. Adjustment for possible
mediation by birthweight, gestational age, and mode of delivery
resulted in attenuation towards the null of the association of pre-
eclampsia with both SBP and DBP (model 5). With one exception,
neither pre-eclampsia nor gestational hypertension was associated
with endothelial dysfunction or any of the other vascular outcomes
in any of the models. In the simple age- and gender-adjusted model
offspring of women who had experienced gestational hypertension
had slightly wider brachial artery diameters (model 1), but adjust-
ment for confounding factors attenuated this to the null.
Of the 4654 participants, 211 (5%) were born preterm of whom
25 had pre-eclampsia. Associations of either pre-eclampsia or
gestational hypertension with all vascular outcomes in this sub-
group who were born preterm were the same as those in offspring
born at term, with point estimates all being very similar in the two
groups and the P-values for interactions (between HDP and
preterm/term) all being .0.5.
As HDP was not associated with outcomes other than offspring
SBP and DBP, the associations with offspring blood pressure could
not explain associations with other outcomes. Associations with
other vascular and biomarker outcomes were essentially
unchanged from those presented with further adjustment for
SBP and DBP.
When all analyses were repeated in the 3062 with complete
data on both sets of outcomes they were essentially unchanged
from those presented here. In all statistical models, the residuals
were approximately normally distributed and in all models
overall model P-values were ,0.0001. There was no evidence of
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Table 1 Correlation coefﬁcients between biomarker and vascular outcomes assessed age 9–11 years (n 5 3062)
HDLc N-HDLc Trigs ApoA1 ApoB C-reactive protein IL-6 SBP DBP FMD PWV DC BD
HDLc 1
N-HDLc 20.20* 1
Trigs 20.44* 0.41* 1
ApoA1 0.82* 0.00**** 20.12* 1
ApoB 20.18* 0.89* 0.22* 20.03**** 1
C-reactive protein 20.22* 0.05** 0.03*** 20.20* 0.10* 1
IL-6 20.18* 20.01**** 0.03*** 20.19* 0.01**** 0.48* 1
SBP 20.05** 0.05** 0.02**** 20.04*** 0.05** 0.07* 0.06** 1
DBP 20.05** 0.03**** 20.01**** 20.06** 0.06** 0.09* 0.07* 0.58* 1
FMD 20.06** 0.03**** 0.07* 20.03**** 0.02**** 0.06** 0.04*** 0.01**** 0.03**** 1
PWV 0.05** 20.05** 20.06** 0.03**** 20.04*** 20.08* 20.03*** 0.09* 0.21* 20.01**** 1
DC 20.05** 20.03*** 20.02*** 20.05** 20.01**** 0.02 0.01**** 20.11* 0.06* 20.13* 20.16* 1
BD 20.06** 20.02**** 0.04**** 20.03**** 20.03*** 0.02**** 0.00**** 0.04** 20.08* 20.01**** 20.13* 20.06* 1
HDLc, high density lipoprotein cholesterol; N-HDLc, non-high density lipoprotein cholesterol; ApoA1, Apolipoprotein A1; ApoB, Apolipoprotein B; IL-6, Interlukin-6; SBP, systolic blood pressure; DBP, diastolic blood pressure; FMD,
ﬂow-mediated dilatation; PWV, pulse wave velocity; DC, distensibility coefﬁcient; BD, Brachial diameter.
*P , 0.001.
**P ≥ 0.001 ,0.01.
***P ≥ 0.01 ,0.05.
****P ≥ 0.05.
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0multicollinearity in any models with all variance inﬂation factors
being between 1.06 and 1.58.
Discussion
In this large general population birth cohort, we found no associ-
ation of either gestational hypertension or pre-eclampsia with off-
spring lipids, apolipoproteins, inﬂammatory markers, FMD, PWV,
DC, or brachial artery diameter, despite associations of HDP
with offspring blood pressure assessed at mean age 9.9 years,
1
and with blood pressure assessed  1 year later at mean age
10.7 years. The associations with blood pressure were somewhat
attenuated by adjustment for maternal and offspring BMI, and
further adjustment for dietary sodium intake, but positive
associations remained. As we found previously,
1 adjustment for
birthweight, gestational age, and mode of delivery resulted in
attenuation of the association of pre-eclampsia with offspring
blood pressure but did not alter the associations of gestational
hypertension with blood pressure.
Our ﬁndings contrast with two previous studies that found
HDP
14 and pre-eclampsia
13 to be associated with lower FMD in
offspring in later life. Both these studies were smaller and were
based on selected populations. In the ﬁrst, all offspring were
born preterm and 19 mother-offspring pairs in which the
mother had experienced HDP were compared with 52 controls
where the mother had normal blood pressure in pregnancy. Of
note, we found no associations of either pre-eclampsia or gesta-
tional hypertension with FMD or other vascular outcomes other
....................................................................................................
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Table 2 Distributions of participant characteristics by hypertensive disorder of pregnancy status
Characteristic Mean (SD) [N] by HDP category P-value
a
No HDP Gestational hypertension Pre-eclampsia
Maternal age (years) 29.0 (4.5) [5035] 28.9 (4.8) [1000] 29.5 (5.4) [137] 0.36
Maternal pre-pregnancy BMI (kg/m
2) 22.5 (3.2) [4567] 24.6 (4.6) [890] 26.1 (6.1) [123] ,0.001
Gestational age (weeks) 39.5 (1.7) [5035] 39.6 (1.7) [1000] 37.6 (3.2) [137] ,0.001
Birthweight (g) 3443 (507) [4975] 3435 (566) [992] 3042 (929) [133] ,0.001
Offspring age (months)
b 118 (4) [4654] 118 (4) [994] 118 (3) [132] 0.98
Offspring BMI (kg/m
2)
b 17.6 (2.8) [4599] 18.1 (3.2) [935] 17.9 (3.3) [132] ,0.001
Offspring waist (mm)
b 62.6 (7.5) [4640] 64.1 (8.6) [943] 63.5 (9.2) [132] ,0.001
Offspring fat mass (kg)
b,c 7.0 (6.8, 7.1) [3403] 7.8 (7.5, 8.1) [715] 7.3 (6.4, 8.2) [86] ,0.001
Offspring HDLc (mmol/L)
b 1.40 (0.31) [3369] 1.38 (0.29) [689] 1.37 (0.30) [88] 0.21
Offspring non-HDLc (mmol/L)
b 2.87 (0.65) [3369] 2.88 (0.64) [689] 2.87 (0.59) [88] 0.76
Offspring triglyceride (mmol/L)
b,c 1.03 (1.01, 1.04) [3369] 1.03 (1.00, 1.06) [689] 0.99 (0.91, 1.09) [88] 0.78
Offspring apolipoprotein A1 (mg/dL)
b 136 (20) [3369] 135 (19) [689] 136 (17) [88] 0.42
Offspring apolipoprotein B (mg/dL)
b 59 (13) [3369] 60 (13) [689] 60 (12) [88] 0.69
Offspring C-reactive protein (mg/L)
b,c 0.27 (0.26, 0.28) [3369] 0.29 (0.26, 0.31) [689] 0.29 (0.23, 0.37) [88] 0.30
Offspring IL6 (pg/mL)
b,c 0.84 (0.82, 0.87) [3363] 0.86 (0.81, 0.91) [688] 0.94 (0.79, 1.11) [86] 0.51
Offspring age (months)
d 128 (3) [5367] 128 (3) [1039] 128 (3) [143] 0.45
Offspring SBP (mmHg)
d 104 (9) [5367] 106 (9) [1039] 107 (11) [143] ,0.001
Offspring DBP (mmHg)
d 60 (8) [5367] 61 (8) [1039] 62 (8) [143] ,0.001
Offspring FMD (mm)
d 0.21 (0.09) [4826] 0.21 (0.09) [921] 0.21 (0.08) [129] 0.47
Offspring PWV (m/s)
d 7.56 (1.23) [5434] 7.54 (1.22) [1061] 7.74 (1.26) [147] 0.20
Offspring DC (% per mmHg)
d,c 11.4 (11.3, 11.6) [4983] 11.2 (10.9, 11.5) [961] 10.9 (10.1, 11.9) [133] 0.33
Brachial artery diameter (mm)
d 2.67 (0.30) [4983] 2.70 (0.31) [961] 2.65 (0.33) [133] 0.06
Binary characteristics [n/N (%) by HDP category]
First pregnancy for mother 2129/4857 (44) 587/970 (60) 91/133 (68) ,0.001
Mother smoked during pregnancy 940/4914 (19) 136/982 (14) 16/135 (12) ,0.001
Mother has university degree 790/4845 (16) 159/960 (16) 15/132 (11) 0.27
Head of household in manual social class 655/4619 (14) 128/918 (14) 21/125 (17) 0.70
Delivery by caesarean section 449/4953 (9) 165/997 (17) 49/137 (36) ,0.001
Infant male 2443/5035 (49) 520/1000 (52) 76/137 (55) 0.04
HDP, hypertensive disorder of pregnancy; BMI, body mass index; HDLc, high density lipoprotein cholesterol; IL-6, Interlukin-6; SBP, systolic blood pressure; DBP, diastolic blood
pressure; FMD, ﬂow-mediated dilatation; PWV, pulse wave velocity; DC, distensibility coefﬁcient.
aF-test for continuous characteristics and x
2 for binary characteristics; both with 2 df testing the null hypothesis that distributions of characteristics are the same across the three
HDP categories.
bAssessed at 9-year assessment.
cGeometric means and 95% conﬁdence intervals of these means are presented.
dAssessed at 10-year assessment.
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infant was born preterm (n ¼ 215, of whom 25 had pre-eclampsia)
and no evidence that any of the associations that we examined dif-
fered by whether the offspring were born preterm or at term. In
the second study (n ¼ 24 with pre-eclampsia and 27 controls
with normal blood pressure in pregnancy), mothers and offspring
had spent all of their lives living at high altitude and the authors
argued that the stress on the vascular system at high altitude
allowed associations to emerge in this population. We are
unable to examine whether associations differ between individuals
living at high altitude and those who do not, but our results suggest
that, in a general population not living at high altitude, maternal
HDP is not associated with cardiovascular risk factors in offspring
beyond the established association with blood pressure. In both of
these previous studies, outcomes were measured when offspring
were somewhat older than in our study, in adolescence in the
ﬁrst
14 and early 20 s in the second.
13 It is possible that associations
with a wider range of vascular outcomes do not emerge until after
puberty and with further follow-up of the ALSPAC cohort we will
have the potential to examine this. Indeed high blood pressure is a
risk factor for later endothelial dysfunction. It is therefore possible
that the primary effect of maternal HDP on offspring vascular risk
is elevated blood pressure, but that this then leads to later adverse
vascular outcomes, including endothelial dysfunction in later life.
We also found no long-term associations of HDP with off-
spring markers of chronic inﬂammation, lipids, or apolipopro-
teins, the latter being consistent with a previous, but much
smaller, study that found no association of HDP with offspring
lipids, but a positive association with blood pressure.
5 Our ﬁnd-
ings are also consistent with the one study that has examined
the association of HDP with offspring cardiovascular disease
events, which found it to be associated with offspring stroke
risk (more strongly inﬂuenced by blood pressure than lipids),
but not coronary heart disease risk.
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Table 3 Multivariable associations of hypertensive disorder of pregnancy with offspring lipids, apolipoproteins, and
inﬂammatory markers at mean age 9.9 years (n 5 3537 with complete data on all variables used in any model)
Outcome Model Mean difference (95% CI)
No HDP, n 5 2869 Gestational HT, n 5 598 Pre-eclampsia, n 5 70
HDLc (mmol/L) M1 0 20.02 (20.05, 0.01) 20.04 (20.11, 0.03)
M2 0 0.00 (20.03, 0.03) 20.02 (20.09, 0.06)
M3 0 20.01 (20.03, 0.02) 20.03 (20.11, 0.04)
M4 0 0.00 (20.02, 0.03) 20.04 (20.11, 0.03)
Non-HDLc (mmol/L) M1 0 0.03 (20.03, 0.08) 0.03 (20.12, 0.18)
M2 0 0.01 (20.06, 0.07) 0.00 (20.15, 0.15)
M3 0 0.01 (20.05, 0.07) 20.01 (20.16, 0.14)
M4 0 0.01 (20.05, 0.06) 0.01 (20.14, 0.16)
Triglycerides (ratio geometric means)
a M1 1 1.00 (0.96, 1.04) 0.97 (0.86, 1.08)
M2 1 0.98 (0.94, 1.02) 0.95 (0.84, 1.06)
M3 1 0.98 (0.94, 1.02) 0.96 (0.85, 1.07)
M4 1 0.97 (0.93, 1.01) 0.97 (0.86, 1.07)
Apolipoprotein A1 (mg/dL) M1 0 21.30 (23.06, 0.45) 20.44 (25.18, 4.29)
M2 0 20.46 (22.28, 1.37) 0.72 (24.08, 5.51)
M3 0 20.61 (22.43, 1.22) 0.23 (25.12, 4.66)
M4 0 20.09 (21.89, 1.72) 20.61 (25.43, 4.21)
Apolipoprotein B (mg/dL) M1 0 0.63 (20.50, 1.76) 1.09 (21.96, 4.14)
M2 0 0.33 (20.85, 1.50) 0.57 (22.52, 3.66)
M3 0 0.28 (20.90, 1.45) 0.49 (22.66, 3.64)
M4 0 0.39 (20.77, 1.55) 0.85 (22.23, 3.94)
C-reactive protein (ratio geometric means)
a M1 1 1.13 (1.01, 1.25) 1.19 (0.89, 1.47)
M2 1 1.03 (0.91, 1.14) 1.05 (0.76, 1.35)
M3 1 1.02 (0.91, 1.13) 1.04 (0.76, 1.33)
M4 1 0.99 (0.88, 1.09) 1.10 (0.81, 1.38)
IL-6 (ratio geometric means)
a M1 1 1.08 (1.00, 1.16) 1.16 (0.95, 1.36)
M2 1 1.02 (0.94, 1.11) 1.09 (0.88, 1.30)
M3 1 1.02 (0.94, 1.11) 1.04 (0.75, 1.27)
M4 1 0.99 (0.89, 1.08) 1.09 (0.88, 1.30)
M1: Adjusted for offspring sex and age at time of outcome measurement.
M2: Maternal confounder adjusted model: as M1 plus adjustment for maternal age, nulliparity, smoking during pregnancy, pre-pregnancy BMI, education and head of household
social class.
M3: Confounder adjusted model taking account of offspring adiposity: as M2 plus adjustment for offspring BMI, height and height-squared (NB: substituting BMI for offspring waist
circumference or for offspring fat mass did not substantively alter any of the results).
M4: Mediator for intrauterine characteristics model: as M3 plus adjustment for birthweight, gestational age and mode of delivery.
HDLc, high density lipoprotein cholesterol; IL-6, Interlukin-6.
aResults for these outcomes are ratios of geometric means. As indicated in column 1 the null value for these results is 1 (it is 0 for other results which are mean differences).
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hypertension with offspring blood pressure, but not with other
cardiovascular risk factors, would support a mechanism that links
higher blood pressure in mothers and their offspring. Such mech-
anisms would include the existence of common genetic variants
that inﬂuence both HDP and higher offspring blood pressure,
and also shared familial environmental factors that are speciﬁcally
(or particularly strongly) associated with blood pressure. Greater
adiposity is strongly associated with higher blood pressure
outside of pregnancy and also with higher blood pressure during
pregnancy
21 and with HDP.
1 Our ﬁndings suggest that familial cor-
relations of adiposity may in part explain the association of HDP
with offspring higher blood pressure. However, positive associ-
ations remained after adjustment for maternal and offspring BMI
and greater adiposity is also strongly associated with markers of
inﬂammation and adverse lipid levels and yet we found no associ-
ations of HDP with these. Dietary salt intake is a speciﬁc risk factor
for higher blood pressure and therefore shared familial dietary pat-
terns in relation to salt intake could result in a speciﬁc association
of maternal blood pressure in pregnancy with offspring later blood
pressure. We found that there was some attenuation of the associ-
ation of pre-eclampsia with offspring blood pressure after adjust-
ment for offspring dietary sodium intake, but this adjustment had
no effect on the association of gestational hypertension with off-
spring blood pressure. Even after adjustment for maternal and off-
spring BMI and offspring dietary sodium intake, as well as other
potential confounders a positive association of both gestational
hypertension and pre-eclampsia with offspring blood pressure,
.............................................................................................................
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Table 4 Multivariable associations of hypertensive disorder of pregnancy with offspring vascular phenotypes at mean
age 10.7 years (n 5 4654 with complete data on all variables used in any model)
Outcome Model Mean difference (95% CI)
No HDP, n 5 3781 Gestational HT, n 5 771 Pre-eclampsia, n 5 102
SBP (mmHg) M1 0 2.54 (1.83, 3.25) 2.59 (0.80, 4.39)
M2 0 2.11 (1.39, 2.85) 2.27 (0.49, 4.04)
M3 0 2.04 (1.33, 2.76) 2.09 (0.31, 3.89)
M4 0 2.04 (1.33, 2.76) 1.82 (0.03, 3.62)
M5 0 2.09 (1.36, 2.81) 1.30 (20.54, 2.81)
DBP (mmHg) M1 0 1.38 (0.76, 1.99) 1.72 (0.16, 3.28)
M2 0 1.13 (0.50, 1.77) 1.26 (20.32, 4.03)
M3 0 1.10 (0.47, 1.73) 1.12 (20.49, 2.72)
M4 0 1.10 (0.47, 1.73) 1.40 (20.17, 2.98)
M5 0 1.10 (0.47, 1.73) 1.26 (20.32, 2.85)
FMD (mm) M1 0 0.00 (20.01, 0.01) 0.00 (20.02, 0.02)
M2 0 20.01 (20.01, 0.01) 20.01 (20.03, 0.01)
M3 0 20.01 (20.01, 0.00) 20.01 (20.03, 0.01)
M4 0 20.01 (20.01, 0.01) 20.01 (20.03, 0.01)
M5 0 20.01 (20.01, 0.01) 20.01 (20.02, 0.01)
PWV (m/s) M1 0 20.05 (20.15, 0.04) 0.08 (20.16, 0.32)
M2 0 20.03 (20.13, 0.07) 0.11 (20.13, 0.36)
M3 0 20.02 (20.12, 0.07) 0.07 (20.17, 0.32)
M4 0 20.03 (20.13, 0.07) 0.10 (20.15, 0.35)
M5 0 20.02 (20.12, 0.07) 0.06 (20.17, 0.31)
DC (ratio of geometric means)
a M1 1 0.98 (0.94, 1.02) 0.94 (0.84, 1.04)
M2 1 0.98 (0.94, 1.02) 0.94 (0.84, 1.03)
M3 1 0.97 (0.94, 1.01) 0.93 (0.83, 1.03)
M4 1 0.97 (0.94, 1.01) 0.93 (0.83, 1.03)
M5 1 0.97 (0.94, 1.01) 0.93 (0.83, 1.03)
Brachial artery diameter (mm) M1 0 0.024 (0.001, 0.048) 20.043 (20.102, 0.016)
M2 0 0.010 (20.015, 0.034) 20.069 (20.129, 20.008)
M3 0 0.014 (20.010, 0.039) 20.059 (20.119, 0.002)
M4 0 20.002 (20.002, 20.20) 20.036 (20.092, 0.019)
M5 0 0.000 (20.022, 0.022) 20.037 (20.092, 0.018)
M1: Adjusted for offspring sex and age at time of outcome measurement.
M2: Maternal confounder adjusted model: as M1 plus adjustment for maternal age, nulliparity, smoking during pregnancy, pre-pregnancy BMI, education and head of household
social class.
M3: Confounder adjusted model taking account of offspring adiposity: as M2 plus adjustment for offspring BMI, height and height-squared (NB: substituting BMI for offspring waist
circumference or for offspring fat mass did not substantively alter any of the results).
M4: As M3 plus adjustment for offspring dietary sodium.
M5: Mediator for intrauterine characteristics model: as M3 plus adjustment for birthweight, gestational age and mode of delivery.
SBP, systolic blood pressure; DBP, diastolic blood pressure; FMD, ﬂow-mediated dilatation absolute; PWV, pulse wave velocity; DC, distensibility coefﬁcient.
aResults for these outcomes are ratios of geometric means. As indicated in column 1 the null value for these results is 1 (it is 0 for other results which are mean differences).
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genetic or familial environmental characteristics explaining the
associations for HDP with offspring blood pressure, come from
ﬁndings that the association of maternal blood pressure with off-
spring blood pressure is of very similar magnitude to that of
paternal blood pressure with offspring blood pressure.
22 Essential
hypertension in both parents has also been shown to associate
with offspring forearm endothelial dysfunction, with similar magni-
tudes of association for each parent.
23 Thus, even in studies ﬁnding
associations with endothelial function this may be due to shared
familial characteristics rather than speciﬁc intrauterine effects.
We do not have measurements of blood pressure in the fathers
in this study to be able to compare father-offspring blood pressure
associations with the mother-offspring associations reported here.
Others have suggested that HDP results in vasculotoxic factors
beingreleasedintothematernalcirculationwhichcrosstheplacenta
and have adverse inﬂuences on foetal development, resulting in
increased risk of vascular dysfunction and chronic inﬂammation in
later life of the offspring.
13 Our results from the largest study to
date in a general population do not support this assertion, although
asacknowledgedaboveitispossiblethatassociationswithoutcomes
other than blood pressure may emerge as these offspring age.
Study strengths and limitations
The main strength of our study is that it is considerably larger than
previous studies and examines a wider range of offspring outcomes
that have been suggested as being plausibly inﬂuenced by exposure
to maternal HDP in utero. Consistent with all general population
birth cohorts, our study is affected by cohort attrition and
missing data (Figure 1). The distribution of HDP was similar in all
women with obstetric data, those whose child had attended
either of the clinics and also those who had complete data on
any variable included in any analyses. In a number of sensitivity ana-
lyses, using multivariate multiple imputation, results were similar to
those presented here including only those with complete data.
These ﬁndings suggest that our results have not been markedly
biased by loss to follow-up or missing data. Offspring blood tests
were completed on non-fasting blood samples but the majority
of measures are not appreciably altered by this approach.
24,25
Assessment of dietary sodium intake was by diet diaries rather
than excretion in 24 h urine and measurement error in this
dietary assessment may mean that we have been unable to fully
account for its contribution to the observed association. All of
our vascular measurements were done on the brachial artery
and therefore do not necessarily reﬂect central arterial stiffness.
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However, these assessments are consistent with those used in
other studies of these associations and despite blood pressure
ampliﬁcation from central to more peripheral arteries, peripheral
measurements do correlate strongly with central ones and it is
unlikely that important strong associations with central stiffness
have been missed here.
In conclusion, our ﬁndings suggest that there is a speciﬁc associ-
ation of both types of HDP with greater offspring blood pressure
but that HDP is not associated with FMD, PWV, DC, lipids,
apolipoproteins, or inﬂammatory markers.
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